Company: MVIS
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001641172-25-022632
Chunk: 171

Company: MICROVISION, INC.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 3
Chunk 171
---
 than us and may now have access to more entrenched sales channels. This historical imbalance in financial resources and
access could result for us in reduced revenues, lower margins or loss of market share, any of which could reduce the value of our business.
Additionally, for a variety of reasons, customers may choose to purchase from suppliers that have substantially greater financial or
other resources than we have.

Risks
Related to Fundraising Transactions and the Convertible Note

Our
stockholders will experience further dilution if we issue additional equity securities in future fundraising transactions.

We
are generally not restricted from issuing additional common stock, including any securities that are convertible into or exchangeable
for, or that represent the right to receive, common stock. If we issue additional common stock, or securities convertible into or exchangeable
or exercisable for common stock (including additional convertible notes to the holder of the convertible note issued by us in October
2024 pursuant to the securities purchase agreement dated October 14, 2024), our stockholders could experience additional dilution, and
any such issuances may result in downward pressure on the price of our common stock.

Sales
of shares of our common stock by the holder of the October 2024 convertible note may cause our stock price to decline.

Sales
of substantial amounts of our shares of common stock in the public market by the holder of the convertible note issued by us in October
2024, or the perception that those sales may occur, could cause the market price of shares of our common stock to decline and impair
our ability to raise capital through the sale of additional shares of our common stock.

We
do not currently intend to pay dividends on our common stock, and any return to investors is expected to come, if at all, only from potential
increases in the price of our common stock.

At
the present time, we intend to use available funds to finance our operations. Accordingly, while any payment of dividends would be at
the discretion of our board of directors, no cash dividends on our common shares have been declared or paid by us and we have no intention
of paying any such dividends in the foreseeable future. Any return to investors is expected to come, if at all, only from potential increases
in the price of our common stock.

There
are risks associated with our outstanding convertible note, and any additional convertible notes that may be issued under the October
2024 securities purchase agreement, that could adversely affect our business and financial condition.

On
October 23, 202